exclusive focus on the life sciences —
active early-stage investments —
strong track record
From its inception, GLSV has benefited from a clear focus by investing exclusively in the life sciences. The emphasis is on securing attractive investment opportunities through careful identification of companies offering superior technologies and customer benefit. Predominantly, investments have been made in early-stage innovative companies.
GLSV has invested in many enterprises committed to innovative science and technologies. The GLSV portfolio includes companies active in many areas of the life sciences including:
- Indication-specific genomics
- Genomics tools
- Medical devices
- Healthcare services
These companies are shaping the future direction of biological science and modern health care.
A list of some of our Portfolio Companies.